However, our data indicate negative regulation of ciliogenesis and Hh signaling by NRF2, which is fully supported by our results utilizing pharmacological and genetic manipulation of NRF2 in multiple lung cancer cell lines as well as MEFs. The gene discussed is NFE2L2; the disease is lung carcinoma.